WEREWOLF THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $1.00K, a 97.56% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $41.00K, a 46.05% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $76.00K, a 68.89% increase year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $30.00K, a 99.73% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $93.00K, a 99.41% decline from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $15.74M, a 85.59% decline from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2021 was $109.22M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $1.00K S-4 · filed 2026-09-22 | |
| 2025-12-31 | $89.00K S-4 · filed 2026-09-22 | |
| 2025-06-30 | $41.00K S-4 · filed 2026-09-22 | |
| 2024-12-31 | $142.00K S-4 · filed 2026-09-22 | |
| 2024-06-30 | $76.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $93.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $30.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $45.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $8.61M 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $15.74M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $11.02M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $3.34M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $109.22M 10-K · filed 2023-03-23 | |
| 2021-06-30 | $109.22M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |